PRACTICE POINTER Contraceptive and hormonal treatment options for women with history of venous thromboembolism

被引：13
|
作者：
Stam-Slob, Manon C. [1 ,3 ]
Lambalk, Cornelis B.
van de Ree, Marcel A. [2 ,4 ]
机构：
[1] Diakonessenhuis Utrecht, Dept Internal Med, NL-3508 TG Utrecht, Netherlands
[2] Diakonessenhuis Utrecht, Dept Internal Med, Internal & Vasc Med, NL-3508 TG Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Utrecht, Netherlands
[4] Vrije Univ Amsterdam Med Ctr, Dept Obstet & Gynecol, Gynaecol, NL-1007 MB Amsterdam, Netherlands
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2015年 / 351卷
关键词：
ORAL-CONTRACEPTIVES; RISK; NORGESTIMATE; THROMBOSIS; ESTROGEN; THERAPY; EVENTS;
D O I：
10.1136/bmj.h4847
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：7
相关论文
共 47 条
  • [21] Treatment of venous thromboembolism in a 22-year-old woman taking an oral contraceptive pill
    Shafran, Daniel M.
    Wu, Cynthia
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2017, 189 (47) : E1459 - E1460
  • [22] Oral Contraceptive Types in Relation to ABO Blood Groups Among Saudi Women of Different Reproductive Age Groups and Impact on Venous Thromboembolism
    Mohamed, Abdulrahman B. O.
    Al-Ama, Nabeel
    Al Kreathy, Huda
    Ahmed, Khalid H. B.
    Al Amri, Turki
    Harakeh, Steve
    Mousa, Shaker A.
    De Laat, Bas
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2020, 26
  • [23] Prophylaxis and treatment of venous thromboembolism in cancer patients: a systemic review and critical appraisal of clinical practice guidelines
    Chen, Qinchang
    Chen, Qingui
    Lin, Xixia
    Li, Lingling
    Li, Yonghui
    Tian, Zhenluan
    Liu, Wei
    Huang, Kai
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (01) : 197 - +
  • [24] Incidence of ovarian endometrioma among women with peritoneal endometriosis with and without a history of hormonal contraceptive use
    Kavoussi, Shahryar K.
    Odenwald, Kate C.
    As-Sanie, Sawsan
    Lebovic, Dan I.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2017, 215 : 220 - 223
  • [25] Treatment and secondary prevention of venous thromboembolism in cancer patients Current strategies and new therapeutic options
    Ay, C.
    Pabinger, I.
    HAMOSTASEOLOGIE, 2012, 32 (02): : 139 - 144
  • [26] The association between estradiol levels, hormonal contraceptive use, an responsiveness to one-session-treatment for spider phobia in women
    Graham, Bronwyn M.
    Li, Sophie H.
    Black, Melissa J.
    Ost, Lars-Goran
    PSYCHONEUROENDOCRINOLOGY, 2018, 90 : 134 - 140
  • [27] Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review
    Mohllajee, AP
    Curtis, KM
    Martins, SL
    Peterson, HB
    CONTRACEPTION, 2006, 73 (02) : 166 - 178
  • [28] Disparities in menstrual bleeding management during acute venous thromboembolism treatment: A review of UK practice and a call for clinical studies
    Hassan, Eman
    Sutton, David
    Buka, Richard J.
    Lowe, Gillian
    Nandra, Taran
    Jacob, Nkemdirim
    Rose, Lucy
    Alhamdi, Yasir
    Nicolson, Phillip L. R.
    THROMBOSIS RESEARCH, 2025, 247
  • [29] Transdermal estrogen therapy effects on fibrinogen levels in women with a past history of venous thromboembolism: a pilot study
    Margarido, P. F. R.
    Bagnoli, V. R.
    Maggio da Fonseca, A.
    Maciel, G. A. R.
    Soares, J. M., Jr.
    D'Amico, E. A.
    Baracat, E. C.
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2011, 38 (03) : 232 - 235
  • [30] Association of elevated soluble P-selectin levels with fetal loss in women with a history of venous thromboembolism
    Ay, Cihan
    Kaider, Alexandra
    Koder, Silvia
    Husslein, Peter
    Pabinger, Ingrid
    THROMBOSIS RESEARCH, 2012, 129 (06) : 725 - 728
12345